PortfoliosLab logo
SANM vs. GMAB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SANM and GMAB is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

SANM vs. GMAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sanmina Corporation (SANM) and Genmab A/S (GMAB). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

SANM:

0.63

GMAB:

-0.99

Sortino Ratio

SANM:

1.15

GMAB:

-1.35

Omega Ratio

SANM:

1.16

GMAB:

0.83

Calmar Ratio

SANM:

0.30

GMAB:

-0.54

Martin Ratio

SANM:

2.66

GMAB:

-1.38

Ulcer Index

SANM:

9.27%

GMAB:

24.61%

Daily Std Dev

SANM:

36.82%

GMAB:

33.16%

Max Drawdown

SANM:

-99.66%

GMAB:

-84.20%

Current Drawdown

SANM:

-77.42%

GMAB:

-60.26%

Fundamentals

Market Cap

SANM:

$4.27B

GMAB:

$12.15B

EPS

SANM:

$4.32

GMAB:

$1.84

PE Ratio

SANM:

18.51

GMAB:

10.52

PEG Ratio

SANM:

0.92

GMAB:

1.09

PS Ratio

SANM:

0.54

GMAB:

0.56

PB Ratio

SANM:

1.94

GMAB:

2.30

Total Revenue (TTM)

SANM:

$7.85B

GMAB:

$18.10B

Gross Profit (TTM)

SANM:

$668.98M

GMAB:

$17.26B

EBITDA (TTM)

SANM:

$482.12M

GMAB:

$6.35B

Returns By Period

In the year-to-date period, SANM achieves a 5.66% return, which is significantly higher than GMAB's -7.24% return. Over the past 10 years, SANM has outperformed GMAB with an annualized return of 14.10%, while GMAB has yielded a comparatively lower 8.41% annualized return.


SANM

YTD

5.66%

1M

7.11%

6M

-3.99%

1Y

23.13%

5Y*

23.58%

10Y*

14.10%

GMAB

YTD

-7.24%

1M

7.50%

6M

-16.12%

1Y

-32.87%

5Y*

-7.30%

10Y*

8.41%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SANM vs. GMAB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SANM
The Risk-Adjusted Performance Rank of SANM is 7272
Overall Rank
The Sharpe Ratio Rank of SANM is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of SANM is 7070
Sortino Ratio Rank
The Omega Ratio Rank of SANM is 6969
Omega Ratio Rank
The Calmar Ratio Rank of SANM is 6666
Calmar Ratio Rank
The Martin Ratio Rank of SANM is 7878
Martin Ratio Rank

GMAB
The Risk-Adjusted Performance Rank of GMAB is 1010
Overall Rank
The Sharpe Ratio Rank of GMAB is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of GMAB is 88
Sortino Ratio Rank
The Omega Ratio Rank of GMAB is 88
Omega Ratio Rank
The Calmar Ratio Rank of GMAB is 1717
Calmar Ratio Rank
The Martin Ratio Rank of GMAB is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SANM vs. GMAB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanmina Corporation (SANM) and Genmab A/S (GMAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current SANM Sharpe Ratio is 0.63, which is higher than the GMAB Sharpe Ratio of -0.99. The chart below compares the historical Sharpe Ratios of SANM and GMAB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

SANM vs. GMAB - Dividend Comparison

Neither SANM nor GMAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SANM vs. GMAB - Drawdown Comparison

The maximum SANM drawdown since its inception was -99.66%, which is greater than GMAB's maximum drawdown of -84.20%. Use the drawdown chart below to compare losses from any high point for SANM and GMAB. For additional features, visit the drawdowns tool.


Loading data...

Volatility

SANM vs. GMAB - Volatility Comparison

The current volatility for Sanmina Corporation (SANM) is 10.25%, while Genmab A/S (GMAB) has a volatility of 11.88%. This indicates that SANM experiences smaller price fluctuations and is considered to be less risky than GMAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

SANM vs. GMAB - Financials Comparison

This section allows you to compare key financial metrics between Sanmina Corporation and Genmab A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00B6.00B20212022202320242025
1.98B
715.00M
(SANM) Total Revenue
(GMAB) Total Revenue
Values in USD except per share items

SANM vs. GMAB - Profitability Comparison

The chart below illustrates the profitability comparison between Sanmina Corporation and Genmab A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20212022202320242025
8.9%
94.1%
(SANM) Gross Margin
(GMAB) Gross Margin
SANM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sanmina Corporation reported a gross profit of 176.24M and revenue of 1.98B. Therefore, the gross margin over that period was 8.9%.

GMAB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Genmab A/S reported a gross profit of 673.00M and revenue of 715.00M. Therefore, the gross margin over that period was 94.1%.

SANM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sanmina Corporation reported an operating income of 91.62M and revenue of 1.98B, resulting in an operating margin of 4.6%.

GMAB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Genmab A/S reported an operating income of 188.00M and revenue of 715.00M, resulting in an operating margin of 26.3%.

SANM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sanmina Corporation reported a net income of 64.21M and revenue of 1.98B, resulting in a net margin of 3.2%.

GMAB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Genmab A/S reported a net income of 195.00M and revenue of 715.00M, resulting in a net margin of 27.3%.